by Mastopexy, commonly known as breast lift surgery, involves the lifting and reshaping of sagging or drooping breasts caused by pregnancy, breastfeeding, weight changes or simply ageing. It helps restore a fuller, youthful contour and firmly supports the breasts. The global mastopexy market is driven by the rising concerns over physical appearance along with increasing awareness regarding cosmetic procedures. In addition, growing participation of women in sports activities leading to changes in breast symmetry accentuates the growth of the market.
The Global Mastopexy Market is estimated to be valued at US$ 2.39 BN in 2024 and is expected to exhibit a CAGR of 6.3% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Global Mastopexy Market Size are Allergan, Sientra, Integra, Polytech, Johnson & Johnson, Cynosure, SOLTA Medical, Syneron Medical, Galderma and Lumenis. Allergan, Johnson & Johnson and Cynosure collectively account for over 35% share of the global market.
The global mastopexy market provides significant opportunities such as increasing medical tourism in developing nations for cosmetic surgery and rising awareness about breast reconstruction after mastectomy. Over the forecast period, Latin America and Asia Pacific are expected to witness highest growth for mastopexy procedures owing to growing medical tourism in these regions.
North America dominates the global mastopexy market due to favorable reimbursement policies and presence of major players. However, Asia Pacific is expected to witness highest growth during the forecast period due to factors such as growing medical tourism, rising disposable income and high burden of breast ptosis among women.
Market Drivers
Increased focus on physical appearance is one of the major drivers for the global mastopexy market. There is rising preference for physical appearance among people owing to growing influence of social media. This has subsequently led to significant growth in aesthetic procedures worldwide. According to American Society of Plastic Surgeons, more than 17.5 million cosmetic surgical and minimally-invasive procedures were performed in the United States in 2020. Other factors such as high prevalence of breast ptosis among ageing and post-pregnancy women and availability of safer breast lift techniques also contribute to the growth of the global mastopexy market.
PEST Analysis
Political: Regulations on plastic surgery and cosmetic procedures differ across countries and states. Favorable regulations promote the growth of mastopexy procedures.
Economic: Rising disposable incomes and increasing focus on aesthetics are some of the major factors driving individuals to opt for mastopexy procedures.
Social: Growing social acceptance of aesthetic enhancement procedures and an increasing emphasis on physical appearance encourage women to undergo mastopexy surgery.
Technological: Advancements in surgical techniques and technology such as minimally invasive procedures reduce procedural risks and complications. Virtual reality and 3D modeling are being used in pre-surgical planning.
Geographical Concentration
North America dominates the Global Mastopexy Market Size in terms of value, due to the high adoption of aesthetic enhancement procedures in the US. High discretionary spending along with the presence of major market players in the region further supports market growth.
Fastest Growing Region
Asia Pacific is expected to be the fastest growing region for the global mastopexy market during the forecast period. Increasing medical tourism, rising focus on aesthetics, and growing disposable incomes in developing countries such as China and India are fueling the adoption of mastopexy procedures in Asia Pacific.
Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
